PASSPORT (Paediatric Adaptive Sepsis Platform Trial) is an adaptive platform trial (APT) evaluating multiple treatments for sepsis under a single platform using adaptive methods. It hopes to find effective treatments quicker and improve global outcomes for critically ill children with sepsis.

We have partnered together to ask YOU what your top priorities are in paediatric sepsis.

In August 2024 attendees at the DFTB24: We Belong conference contributed their ideas – but now we need your help to refine and order the options to find our common top priorities.

By taking part in this survey you will be helping to contribute to cutting edge research in paediatric sepsis. Thanks for being part of the science!